Skip to content
10-Q

Quarterly Report

GreenLight Biosciences Holdings, PBC

0000950170-23-020835

← back to feed
Filed
May 11, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 8, 2023 151.68M sh
Shares Diluted Q1 2023 · Mar 31, 2023 151.61M sh
Shares Diluted Q1 2023 · Mar 31, 2022 113.56M sh
Capex Q1 2023 · Mar 31, 2023 $1.61M
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$31.06M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $32.35M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $68.1M
Stockholders Equity Q1 2023 · Mar 31, 2023 $21.94M
Stockholders Equity Q1 2023 · Dec 31, 2022 $48.06M
Current Liabilities Q1 2023 · Mar 31, 2023 $31.19M
Current Liabilities Q1 2023 · Dec 31, 2022 $35.56M
Total Liabilities Q1 2023 · Mar 31, 2023 $91.75M
Total Liabilities Q1 2023 · Dec 31, 2022 $100.54M
Current Assets Q1 2023 · Mar 31, 2023 $37.7M
Current Assets Q1 2023 · Dec 31, 2022 $71.31M
Total Assets Q1 2023 · Mar 31, 2023 $113.69M
Total Assets Q1 2023 · Dec 31, 2022 $148.6M
Eps Diluted Q1 2023 · Mar 31, 2023 −$0.19
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.34
Eps Basic Q1 2023 · Mar 31, 2023 −$0.19
Eps Basic Q1 2023 · Mar 31, 2022 −$0.34
Sga Expense Q1 2023 · Mar 31, 2023 $8.94M
Net Income Q1 2023 · Mar 31, 2023 −$28.47M
Operating Income Q1 2023 · Mar 31, 2023 −$28.29M
Revenue Q1 2023 · Mar 31, 2023 $3.82M